The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differences in genomic and transcriptomic landscapes of human papillomavirus (HPV)–positive neuroendocrine neoplasms and HPV-positive carcinoma.
 
Emil Lou
Honoraria - Boston Scientific; Daiichi Sankyo/UCB Japan (Inst); GlaxoSmithKline; Novocure
Consulting or Advisory Role - Boston Scientific; Novocure; Novocure; Novocure; Novocure
Research Funding - Intima; Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Minnetronix Medical; NomoCan
 
Harris Benjamin Krause
Employment - Caris Life Sciences
 
Andrew Elliott
Employment - Caris Life Sciences
 
Marya Wahidi
No Relationships to Disclose
 
Janet S. Rader
No Relationships to Disclose
 
Deanna Gek Koon Teoh
Research Funding - Jounce Therapeutics (Inst); Moderna Therapeutics (Inst); Tesaro/GSK (Inst)
 
Soo J Park
Consulting or Advisory Role - Regeneron
Research Funding - BMS (Inst); Incyte (Inst); Merck (Inst); Regeneron (Inst)
 
John Wallbillich
No Relationships to Disclose
 
David Joseph Benjamin
Consulting or Advisory Role - Seagen
 
Arash Rezazadeh
Stock and Other Ownership Interests - ECOM Medical
Consulting or Advisory Role - AstraZeneca; aveo; Bayer; Eisai; Exelixis
Speakers' Bureau - Amgen; AVEO; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Gilead Sciences; Janssen; Myovant Sciences; Pfizer; Sanofi
Research Funding - Amgen (Inst); Arvinas (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Mirati Therapeutics (Inst); navir (Inst); Novartis (Inst); POINT Biopharma (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Exelixis; Janssen
 
Penelope Duerksen-Hughes
No Relationships to Disclose
 
Robert Morris
No Relationships to Disclose
 
Radhika Gogoi
No Relationships to Disclose
 
Fadi Zaiem
No Relationships to Disclose
 
Thomas J Herzog
No Relationships to Disclose
 
Premal H. Thaker
Stock and Other Ownership Interests - Immunon
Consulting or Advisory Role - AADi; AstraZeneca; Eisai; GlaxoSmithKline; Immunogen; Immunon; Iovance Biotherapeutics; Merck; Novocure; R-Pharm; Seagen; Verastem/Pharmacyclics; Zentalis
Research Funding - GlaxoSmithKline (Inst); Merck (Inst)
 
Matthew James Oberley
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Heloisa P. Soares
Honoraria - TM Isotope Technologies Munich SE
Consulting or Advisory Role - AstraZeneca; Ipsen; Novartis; Pfizer; TerSera
(OPTIONAL) Uncompensated Relationships - Healing NET Foundation; NCCN; North American Neuroendocrine Tumor Society
 
Rouba Ali-Fehmi
No Relationships to Disclose